Direct evidence is thin. The claim is plausible and aligns with adjacent findings, but there isn't yet a body of high-quality work that would let us call it well-supported on its own terms.
now think about it if it goes down it's not going down because they're apoe status changed and it's not going down because their age got younger it can only go down because the ratio of ab 42 to ab40 changed so what we're basically saying is we do have a biomarker that measures the change in you know amyloid 42 to 40 and potentially Tau eventually and is that predictive of an improvement I don't know the answer
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.